TP53 and myelodysplastic syndrome: The diagnostic criteria for MDS-SF3B1 include the presence of the SF3B1 mutation with a variant allele frequency (VAF) of at least 10% and the absence of multi-hit TP53 or RUNX1 mutations, 5q deletion, monosomy 7, or complex karyotype [1,20].